Abu Dhabi sovereign investment giant Mubadala has teamed with British Patient Capital to back SV Health Investors' Biotech Crossover Opportunities Fund. The post Mubadala, British Patient Capital back SV Health growth biotech fundraise first appeared
European biotech investor Kurma Partners is well on the way to its €250m goal for its Growth Opportunities fund thanks to a sizeable first close. The post European biotech backer Kurma Ventures seals big first
Biotech-focused investment firm Atlas Venture has hit $450m for the final close of its oversubscribed thirteenth fund. The post Biotech backer Atlas Venture keeps up blistering fundraising pace with $450m Fund XIII close first appeared
Venture capital giant Andreessen Horowitz has powered to $9bn of new capital through a triple fundraise. The post Andreessen Horowitz hauls in $9bn across new triple fundraise first appeared on AltAssets Private Equity News.
European private equity house Montagu has entered exclusive negotiations with Bridgepoint to acquire HTL Biotechnology, a fast-growing biotech and industrial business specialising in pharmaceutical grade biopolymers. The post Bridgepoint sells fast-growing biotech business HTL to Montagu
Italian life sciences investor Panakès Partners has hired Rob Woodman as partner to lead the firm’s newly created biotech investment team. The post Italy’s Panakès Partners hires industry veteran Rob Woodman to lead new biotech
Warburg Pincus-backed Insilico Medicine is reportedly prepping for an IPO which could see it raise up to $300m. The post Insilico said to prep IPO, just a month after Warburg Pincus backing first appeared on
Italian life sciences investor Panakès Partners has struck a €150m first close for its sophomore fundraise amid upping its goal to €180m and expanding into biotech. The post Panakès Partners hits €150m first close for
Private equity giant Carlyle has teamed with with Brighton Park Capital to invest in Bangalore-headquartered enterprise healthtech solutions provider Indegene.
Life science investor Abingworth has upped the ante yet again with its 13th fundraise by hitting a $465m final close for the fund.
Biotech investment specialist Arch Venture Partners has hit a $1.85bn final close for its eleventh flagship fundraise, less than a year after hauling in almost $1.5bn for its predecessor vehicle.
Healthcare and life sciences investor NovaQuest Private Equity has bought contract development and manufacturing organization CoreRx.
BioGeneration Ventures has secured its place among Europe's early-stage biotech investment elite by closing its biggest fundraise to date.
Global alternative investment house Investcorp has bought pharma and biotech clinical trials specialist Sanos Group.
French pharmaceutical giant Sanofi has made a €50m investment in biotech and biopharma venture investment house Jeito Capital.
New Mexico-based Tramway Venture Partners is out raising its debut fund, with a focus on biotech, medtech and healthtech deals.
Private equity and venture capital investment in the biotech sector has scored its busiest month of the past 12 as markets continue their recovery from March's coronavirus shock.
European private equity giant Ardian has entered talks for a sale of food safety business Kersia to fellow buyout house IK Investment Partners.
European life sciences investor Medicxi has hit a €200m final close for its debut secondaries fund amid using the vehicle to pick up six companies from one of the firm's previous funds.
SR One, a venture capital firm focused on the biotech space, is looking to raised up to $400m for its new fund.
